Louis Guzzi, MD, FCCM
Director, Critical Care Medicine
Advent Health Waterman
Tavares, Florida, United States
Disclosure information not submitted.
Combining markers that help delineate sepsis and early AKI may prove a low-risk diagnostic test that decreases MSOF in the increased septic population. The role and clinical relevance of biomarkers, PCT for sepsis, and TIMP-2 and IGFBP-7 for early AKI in this diagnostic and clinical scenario will be discussed.